Point72 Asset Management
KYMR icon

Point72 Asset Management’s Kymera Therapeutics KYMR Stock Holding History

Point72 Asset Management’s Portfolio KYMR Stock Details KYMR Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
2025
Q4 		$13.5M Sell
2025
Q3 		$9.84M Sell
2025
Q2 		$8.05M Buy
2023
Q4 		– Sell
2023
Q3 		$1.13M Buy
2022
Q2 		– Sell
2022
Q1 		$27.6M Buy
2021
Q4 		$3.69M Sell
2021
Q3 		$9.25M Buy
2021
Q2 		$3.28M Buy